Clinical Trial Update: Intranasal Injection of Dexmedetomidine and Bupivacaine in Septoplasty Surgeries [Phase 4]

View source ↗

Summary

Clinical trial update for intranasal dexmedetomidine and intranasal bupivacaine in septoplasty surgeries (Phase 4) with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septoplasty Surgeries

Drugs mentioned

• Bupivacaine (intranasal) (bupivacaine)
• Dexmedetomidine (intranasal) (dexmedetomidine)

Snippet

Sponsor: Cairo University | Conditions: Intranasal Dexmedetomidine, Intranasal Bupivacaine | Phase 4 | Status: UNKNOWN